Practice toolkit
Urology Regenerative Medicine: 90-Day Practice Implementation Toolkit
This toolkit provides a structured timeline to establish clinical governance, train staff, acquire compliant technologies, and launch a urological regenerative service line within 90 days.
This 90-day rollout plan provides urology practices with an operational roadmap to integrate regenerative modalities into clinical care efficiently and compliantly. It outlines month-by-month benchmarks for protocol selection, device procurement, staff education, and patient intake integration. Practice managers and clinicians can follow these structured milestones to minimize operational friction and elevate patient management.
The checklist
- Define target clinical indications (e.g., vasculogenic ED, Peyronie's disease, pelvic pain).
- Evaluate capital equipment and consumable requirements for acoustic wave and autologous biologic procedures.
- Draft comprehensive clinical SOPs and standardized patient informed consent forms.
- Confirm state medical board rules regarding delegation of blood processing and device application.
- Source compliant centrifugation systems and high-yield biologic supplies.
- Conduct staff training on blood collection, sterile preparation, and device application.
- Embed validated diagnostic questionnaires (IIEF-5, SHIM, IPSS) into EHR intake forms.
- Establish clear cash-pay financial agreements and fee schedules for non-covered procedures.
- Execute a soft-launch pilot with a select 5–10 patient cohort to calibrate workflow.
- Review pilot feedback to adjust appointment times and room preparation steps.
- Audit all educational and promotional materials for regulatory and clinical compliance.
- Establish 30-, 60-, and 90-day clinical and financial milestone review schedules.
Days 1–30: Clinical Governance, Modality Selection, and Scope Definition
The initial month centers on establishing the clinical scope and operational framework for your urology practice. Clinicians must evaluate target indications—such as vasculogenic erectile dysfunction, Peyronie's disease, and pelvic floor pain—to select appropriate modalities. Common initial additions include low-intensity extracorporeal shockwave therapy (Li-ESWT) and autologous platelet-rich plasma (PRP) systems.
During this phase, review local state medical board scope-of-practice guidelines regarding procedure delegation and biologic handling. Establish standardized clinical pathways and procure necessary equipment by reviewing verified urology specialty solutions and compliant energy-based devices. Finalize preliminary pricing, non-covered service fee schedules, and patient consent documentation templates.
Days 31–60: Staff Training, Workflow Design, and Supply Chain Readiness
Month two shifts focus to team readiness, protocol standard operating procedures (SOPs), and physical office workflow optimization. Medical assistants, phlebotomists, and nursing staff must complete training on device operations, blood drawing protocols, and processing sterile autologous biologics using dedicated biologic processing supplies.
Integrate intake workflows into your EHR system, ensuring standardized baseline assessment tools—such as the IIEF-5 (International Index of Erectile Function) and SHIM scores—are embedded. Conduct dry runs of treatment visits from intake to post-procedure discharge to identify bottlenecks in room allocation or equipment prep.
Days 61–75: Pilot Launch and Initial Patient Cohort Integration
Initiate a controlled soft launch with a limited cohort of 5 to 10 existing, highly suitable patients. This stage allows the clinical and administrative team to validate scheduling allocations, patient communication scripts, and post-procedure clinical follow-up sequences under real-world conditions.
Collect immediate operational feedback from clinicians and administrative staff following each pilot treatment. Refine appointment timing, room turnaround processes, and billing entry based on real-time observations before expanding patient volume.
Days 76–90: Full Operational Launch, Compliance Review, and Optimization
In the final two weeks of the rollout, transition the service line to full practice availability. Transition active internal educational efforts into routine clinical care discussions and update practice collateral to reflect available non-covered options.
Perform a comprehensive regulatory audit of all patient-facing materials to ensure strict compliance with advertising guidelines and medical board standards. Establish recurring monthly tracking of patient outcomes, retention, and service line operational margins to drive continuous improvement.
Questions practices ask
- What urological conditions are most commonly addressed in an early-stage regenerative service line?
- Practices frequently begin with vasculogenic erectile dysfunction, Peyronie's disease, and chronic pelvic floor discomfort. These conditions align well with non-invasive acoustic wave therapy and autologous biologic protocols, which integrate smoothly into outpatient clinic schedules.
- How should a practice manage procedure delegation between physicians and clinical staff?
- Delegation depends heavily on state medical board regulations. Generally, clinical staff can perform patient intake, phlebotomy, and biologic centrifugation under supervision, while diagnosis, treatment planning, biologic injection, and primary device application remain under direct physician control.
- What objective metrics should be used to monitor clinical outcomes?
- Validated, standardized tools such as the International Index of Erectile Function (IIEF-5), Sexual Health Inventory for Men (SHIM), and International Prostate Symptom Score (IPSS) should be collected at baseline, 30 days, and 90 days post-treatment.
- How can practices ensure regulatory compliance when offering cash-pay regenerative care?
- Practices must clearly separate standard covered urological services from cash-pay regenerative procedures. All patient collateral should accurately reflect clinical evidence without making exaggerated outcome claims or non-compliant off-label representations.
Contact Dallas Regenerative Solutions to consult with our team on equipment, biologic supplies, and operational frameworks tailored to your urology practice. Request a consultation or browse more practice toolkits.
Bring regenerative medicine into your practice.
Talk with our team about biologics, devices, or an AI-powered peptide protocol tailored to your patients.